74
Participants
Start Date
March 1, 2011
Primary Completion Date
July 31, 2014
Study Completion Date
July 31, 2014
pomalidomide
Oral pomalidomide 4 mg on Days 1-21 of 28-day cycle until progressive disease (PD) or unacceptable toxicity
Hôpitaux Universitaire de Genève - Oncologie, Geneva
Royal Prince Alfred Hospital - Institute of Haematology, Camperdown
Calvary Mater Newcastle - Haematology, Waratah
Wollongong Hospital - Haematology, Wollongong
University Hospital Leuven - Hematology, Leuven
Peter McCallum Cancer Institute - Directorate of Cancer Medicine, East Melbourne
The Alfred Hospital - Malignant Haematology & Stem Cell Transplantation, Melbourne
Inselspital, Institut für Medizinische Onkologie, Bern
Frankston Hospital-Peninsula Health - Oncology Day Unit, Frankston
Border Medical Oncology, Wodonga
Princess Alexandra Hospital - Haematology, Brisbane
Royal Adelaide Hospital - SA Pathology Haematology, Adelaide
Odense University Hospital, Odense
Cliniques Universitaires ULC de Mont-Godinne - Hematology, Yvoir
Vejle Hospital - Hematology, Vejle
Aarhus University Hospital, Aarhus
Klinik und Poliklinik für Onkologie - UniversitätsSpital Zürich, Zurich
UZ Gent - Hematology, Ghent
Aalborg Sygemus - Haematology, Aalborg
Ospedale San Luigi AO Luigi Gonzaga - Hematology, Orbassano
A.O.U. San Giovanni Battista - Hematology, Torino
Charles University Hospital - Internal Medicine, Prague
Institut Paoli Calmette - Hematology 1, Marseille
Karolinska University Hospital Huddinge - Center of hematology, Stockholm
Karolinska University Hospital-medicine, Stockholm
University of Athens - Alexandra Hospital, Athens
AO Universitaria San Martino - hematooncology, Genova
Karolinska University Hospital Solna- medicine, Stockholm
Hospital de Donostia - Hematology, Guipúzcoa
Askepios Klinik Altona-Abteilung Hamatologie und Internistische Onkologie, Hamburg
Hospital de La Princesa - Hematology, Madrid
Hospital 12 de Octubre - Hematology, Madrid
Ospedale Guglielmo da Saliceto - hematooncology, Piacenza
CHRU Hôpital Purpan - Hematologie, Toulouse
CHRU - Hôpital du Haut Lévêque - Centre François Magendie Service des maladies du sang, Pessac
Universita degli Studi di Padova - Clinical & Experimental Medicine, Padua
Hospital de Salamanca - Hematology, Salamanca
Hôpital Bretonneau - Hématologie & Thérapie cellulaire, Tours
Hospital Universitario Marqués de Valdecilla - Hematology, Santander
Università degli Studi di Bologna - Policlinico S. Orsola - Hematology, Bologna
Unità di Ematologia Arcispedale S. Maria Nuova - Haematology, Reggio Emilia
CHU Hôtel-Dieu - Hematologie, Nantes
Universitätsklinikum Essen, Klinik für Hämatologie Westdeutsches Tumorzentrum, Essen
Hospital La Fe - Hematology, Valencia
Universitätsklinikum Münster - Medizinische Klinik und Poliklinik A, Münster
CHU Angers - Service des maladies du sang, Angers
CHU Nancy - Hematologie, Vandœuvre-lès-Nancy
CHRU de Lille - Service des maladies du sang, Lille
Centre Hospitalier de la côte basque - Hematologie, Bayonne
Universitätsklinikum Heidelberg - Medizinische Klinik und Poliklinik V, Heidelberg
Centre Hospitalier Lyon sud - Hematologie, Pierre-Bénite
Universitätsklinikum Tübingen - Medizinische Klinik und Poliklinik - Abteilung II, Tübingen
Hôpital Saint Louis - Immuno-hematologie, Paris
CHU Saint Antoine - Service des maladies du sang, Paris
Overlakare Medocomcentrum - Hematology, Uppsala
"Fondazione G. Pascale - Hematology", Napoli
Centre Hospitalier Départemental Vendée - Onco-hematologie, La Roche
Universitätsklinikum Ulm - Klinik fur Innere Medizin III, Ulm
Universitätsklinikum Würzburg - Medizinische Klinik und Poliklinik II, Würzburg
Hematological Research Center under the Russian Academy of Medical Sciences - Hematology & BMT, Moscow
Moscow State Medical Institution Municipal Clinical Hospital n.a. S.P. Botkin - Hematology, Moscow
Russian Research Institute of Hematology and Blood Transfusion - Hematology, Saint Petersburg
State Higher Educational Institution St. Petersburg State Medical University - Onco-hematology, Saint Petersburg
Tom Baker Cancer Center, Calgary
Cross Cancer Institute, Edmonton
British Columbia Cancer Agency, Vancouver Centre, Vancouver
Queen Elizabeth II Health Sciences Centre, Halifax
London Health Sciences Centre, London
Princess Margaret Hospital, University Health Network, Toronto
Maisonneuve-Rosemont Hospital, Montreal
Royal Victoria Hospital, Montreal
Universitatsklinikum Carl Gustav Carus-Medizinische Klinik und Poliklinik I, Dresden
Universitätsklinikum Jena - Klinik fur Innere Medizin II-Hamatologie/Onkologie, Jena
Universitätsklinikum Leipzig - Medizinische Klinik und Poliklinik II, Leipzig
"Policlinico Umberto I, Università La Sapienza di Roma - Hematology", Roma
VUMC - Hematology, Amsterdam
Erasmus Medical Center - Hematology, Rotterdam
University Medical Center - Hematology, Utrecht
Hospital Germans Trias i Pujol - Hematology, Badalona
Hospital Clinic i Provincial de Barcelona - Hematology, Barcelona
Sahlgrenska Hospital, University of Goteborg - Hematology, Gothenburg
Royal Bournemouth Hospital - Haematology, Bournemouth
St James's University Hospital - Haematology, Leeds
St Bartholomew's Hospital - Medical Oncology, London
King's College Hospital - Haematology Clinical Trials, London
Freeman Hospital - Northern Centre for Cancer Care, Newcastle upon Tyne
Nottingham City Hospital - Centre for Clinical Haematology, Nottingham
Derriford Hospital - Haematology, Plymouth
Royal hallamshire Hospital - Haematology, Sheffield
Royal Marsden NHS Foundation Trust - Haematology, Surrey
Royal Wolverhampton Hospitals Trust - Research and Development, Wolverhampton
Lead Sponsor
Celgene
INDUSTRY